Background: Chimeric antigen receptor T cells treatment targeting B cell maturation antigen
(BCMA) is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) …

Melanoma, an aggressive malignant tumor originating from melanocytes in humans, is on
the rise globally, with limited non-surgical treatment options available. Recent …

Cellular therapies, deemed live medicine, have brought a wave of new generation biological
therapies to treat previously untreatable diseases such as cancers and degenerative …

The dynamic roles of T cells in the immune system to recognize and destroy the infected or
mutated cells render T cell therapy a prospective treatment for a variety of diseases …

Cancer is among the leading causes of death worldwide. Therefore, improving cancer
therapeutic strategies using novel alternatives is a top priority on the contemporary scientific …

Cell membrane-coated nanoplatforms for drug delivery have garnered significant attention
due to their inherent cellular properties, such as immune evasion and homing abilities …

Inflammatory and immunosuppressive tumor microenvironment (TME) is responsible for
accelerating lymphoma initiation and progression. Graphdiyne oxide (GDYO) nanosheets …

Abstract Introduction Chimeric Antigen Receptor (CAR)-T cell therapy is a form of adoptive
cell therapy that has demonstrated tremendous results in the treatment of hematopoietic …

Background: Adoptive therapy with genetically modified T cells achieves spectacular
remissions in advanced hematologic malignancies. In contrast to conventional drugs, this …

Simple Summary B-cell lymphomas are the most commonly occurring blood cancer and the
second leading cause of cancer-related death among blood cancers. Chemotherapy and …